BioCryst Pharmaceuticals BCRX Amortization of premium (discount) on investments, net
Amortization of premium (discount) on investments, net at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept bcrx:AmortizationOfPremiumDiscountOnInvestments.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's amortization of premium (discount) on investments, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's amortization of premium (discount) on investments, net?
- BioCryst Pharmaceuticals (BCRX) reported amortization of premium (discount) on investments, net of $251K in Q1 2026.
- How has BioCryst Pharmaceuticals's amortization of premium (discount) on investments, net changed year-over-year?
- BioCryst Pharmaceuticals's amortization of premium (discount) on investments, net increased by 118.1% year-over-year, from -$1.38M to $251K.
- What is the long-term trend for BioCryst Pharmaceuticals's amortization of premium (discount) on investments, net?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's amortization of premium (discount) on investments, net has grown at a 582.2% compound annual growth rate (CAGR), from -$2K to -$4.33M.
- What does amortization of premium (discount) on investments, net mean?
- Reflects the non-cash adjustment to the carrying value of investment securities to account for the amortization of premiums or the accretion of discounts over the holding period. This adjustment aligns the reported interest income with the effective yield of the investment portfolio. It is a standard accounting practice used to normalize investment returns on the income statement.